CLOs on the Move

Bryan A. Stirrat

www.bas.com

 
Bryan A. Stirrat is a Diamond Bar, CA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million
  • www.bas.com
  • 1360 Valley Vista Dr
    Diamond Bar, CA USA 91765
  • Phone: 909.860.7777

Executives

Name Title Contact Details

Similar Companies

Omnilytics Inc

Omnilytics Inc is a Salt Lake City, UT-based company in the Business Services sector.

AECI Mining

AECI Mining is a leading partner in making mining safer and more efficient for a better world. We offer state-of-the-art mining chemicals that optimise mineral processing, ensuring efficiency and environmental responsibility. Our explosives portfolio caters to diverse blasting needs, enhancing safety and precision in mining operations. By prioritising sustainability and safety, our mining chemicals and explosives offerings underscore AECI Minings dedication to propelling the global mining sector towards a responsible and technologically advanced future.

Foreign Ink

Foreign Ink Ltd. is a Minneapolis, MN-based company in the Business Services sector.

The Staffing Solutions Group

The Staffing Solutions Group is a Pasadena, CA-based company in the Business Services sector.

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.